Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

BackgroundBenzodiazepine (BZD) misuse is a significant public health problem, particularly in conjunction with opioid use, due to increased risks of overdose and death. One putative mechanism underlying BZD misuse is affective dysregulation, via exaggerated negative affect (e.g., anxiety, depression...

Full description

Bibliographic Details
Main Authors: Mark K. Greenwald, Tabitha E. H. Moses, Leslie H. Lundahl, Timothy A. Roehrs
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Psychiatry
Subjects:
benzodiazepine
demand
anhedonia
affective dysregulation
opioid use disorder
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1103739/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1103739/full

Similar Items